Q3 FY26 results: revenue and profit decline, margins compress
LXCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q3 FY26 standalone revenue Rs 706.87 crore, down 8% YoY. 9M revenue Rs 2,085.20 crore, down 6.5%. Q3 PAT Rs 19.83 crore vs Rs 27.82 crore. 9M PAT fell 37% to Rs 56.74 crore. Margins compressed sharply. Depreciation change to straight line boosted Q3 profits by about Rs 29 crore. Reversed Rs 40.73 crore of electricity liabilities. Comparatives restated for amalgamation of subsidiary YFCPL. Board approved reappointment of Independent Director.
Revenue and profit fell with sharp margin compression. Depreciation method change and one-time electricity liability reversal inflated reported numbers.